Medpace Holdings - 9 Year Stock Price History | MEDP
- The all-time high Medpace Holdings stock closing price was 457.29 on July 16, 2024.
- The Medpace Holdings 52-week high stock price is 459.77, which is 35.1% above the current share price.
- The Medpace Holdings 52-week low stock price is 302.01, which is 11.2% below the current share price.
- The average Medpace Holdings stock price for the last 52 weeks is 370.92.
Medpace Holdings Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 344.5804 | 334.7500 | 360.9700 | 327.8600 | 340.2200 | 2.40% |
2024 | 366.7217 | 305.5900 | 457.2900 | 284.8700 | 332.2300 | 8.38% |
2023 | 235.2818 | 208.2800 | 312.6800 | 174.3100 | 306.5300 | 44.31% |
2022 | 167.3194 | 214.3100 | 226.5700 | 130.2000 | 212.4100 | -2.40% |
2021 | 179.6718 | 134.4200 | 227.9000 | 132.0200 | 217.6400 | 56.35% |
2020 | 103.5964 | 82.9700 | 149.1900 | 61.7100 | 139.2000 | 65.60% |
2019 | 67.7122 | 52.4000 | 85.8900 | 49.3800 | 84.0600 | 58.81% |
2018 | 46.6866 | 37.1400 | 63.9800 | 32.0250 | 52.9300 | 45.97% |
2017 | 31.4778 | 35.9100 | 38.3100 | 22.1800 | 36.2600 | 0.53% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $10.506B | $2.109B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $150.197B | 27.76 |
Elevance Health (ELV) | United States | $90.566B | 11.84 |
CVS Health (CVS) | United States | $82.065B | 12.01 |
Cencora (COR) | United States | $47.211B | 17.13 |
DiDi Global (DIDIY) | China | $23.282B | 0.00 |
Natera (NTRA) | United States | $22.205B | 0.00 |
ICON (ICLR) | Ireland | $16.651B | 14.81 |
BioMerieux (BMXMF) | France | $14.074B | 0.00 |
Doximity (DOCS) | United States | $14.002B | 72.82 |
Revvity (RVTY) | United States | $13.962B | 23.41 |
Viatris (VTRS) | United States | $13.201B | 4.07 |
Solventum (SOLV) | United States | $12.870B | 0.00 |
Avantor (AVTR) | United States | $11.909B | 17.49 |
CochLear (CHEOY) | Australia | $11.330B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
HealthEquity (HQY) | United States | $9.682B | 48.57 |
Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
Organon (OGN) | United States | $4.041B | 4.12 |
Sotera Health (SHC) | United States | $3.829B | 20.49 |
BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
Concentras Parent (CON) | United States | $2.981B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
Progyny (PGNY) | United States | $2.033B | 41.17 |
PACS (PACS) | United States | $2.010B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
Premier (PINC) | United States | $1.726B | 11.05 |
Agilon Health (AGL) | United States | $1.492B | 0.00 |
Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
CareDx (CDNA) | United States | $1.254B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
Embecta (EMBC) | United States | $0.838B | 5.74 |
Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
DocGo (DCGO) | United States | $0.513B | 19.35 |
SBC Medicals (SBC) | United States | $0.483B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
MultiPlan (MPLN) | United States | $0.477B | 0.00 |
InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
Enhabit (EHAB) | United States | $0.424B | 36.70 |
Nutex Health (NUTX) | United States | $0.335B | 0.00 |
LifeMD (LFMD) | United States | $0.326B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
Beauty Health (SKIN) | United States | $0.199B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
Biodesix (BDSX) | United States | $0.134B | 0.00 |
So-Young (SY) | China | $0.114B | 19.40 |
IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
ModivCare (MODV) | United States | $0.079B | 4.29 |
Oncology Institute (TOI) | United States | $0.068B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.62 |
Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
OncoCyte (OCX) | United States | $0.047B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
KindlyMD (KDLY) | United States | $0.018B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |